An agenda for research on adverse drug reactions
Disease mongering – a challenge for everyone involved in healthcare
An integrated model for the effect of budesonide on ACTH and cortisol in healthy volunteers
Flavonoids inhibit the platelet TxA2 signalling pathway and antagonize TxA2 receptors (TP) in platelets and smooth muscle cells
Nitroglycerin protects the endothelium from ischaemia and reperfusion
Population pharmacokinetics of melphalan in paediatric blood or marrow transplant recipients
Effect of renal impairment on the pharmacokinetics of bupropion and its metabolites
Desloratadine dose selection in children aged 6 months to 2 years
Influence of the CYP3A5 and MDR1 genetic polymorphisms on the pharmacokinetics of tacrolimus in healthy Korean subjects
Cardiovascular toxicity due to venlafaxine poisoning in adults
Evidence of zolpidem abuse and dependence
Carisoprodol use and abuse in Norway. A pharmacoepidemiological study
Exposure-toxicity relationships for tipifarnib in cancer patients
Perception of risk of adverse drug reactions by medical students
Dihydropyrimidine dehydrogenase activity and the IVS14+1G>A mutation in patients developing 5FU-related toxicity
Age dependent systemic exposure to inhaled salbutamol
Investigation on pharmacokinetics of mycophenolic acid in Chinese adult renal transplant patients
Safety of amlodipine use in patients with acute intermittent porphyria
Ethnopharmacology of Medicinal Plants